MBIO Mustang Bio, Inc. - Common Stock
MBIO Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
MBIO Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Financial Health Debt, liquidity, solvency — balance sheet strength
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
MBIO Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
- Strong Buy 2 28.6%
- Buy 4 57.1%
- Hold 1 14.3%
- Sell 0 0.0%
- Strong Sell 0 0.0%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| Dec. 31, 2024 | $-37.95 | $-8.16 | -29.8% |
| Sept. 30, 2024 | $-2.00 | $-6.63 | 4.6% |
| Dec. 31, 2023 | $-43.00 | $-67.83 | 24.8% |
| Sept. 30, 2023 | $-70.00 | $-65.03 | -5.0% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| MBIO | — | -2.5 | — | — | -30.9% | — |
| GOVX | $296.2K | — | -37.1% | -862.3% | -645.9% | — |
| LABT | — | — | — | — | — | — |
| BCAB | — | -0.6 | — | — | — | — |
| TCRT | — | -1.5 | -50.0% | — | — | — |
| APVO | $9M | -0.1 | — | — | -217.2% | — |
| MBRX | — | — | — | — | — | — |
| HCWB | — | -0.1 | -97.9% | -14677.1% | -586.8% | 20.0% |
| REVB | — | — | — | — | — | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 13
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | · | · | · | · | · | · | · | $2M | $100.0K | $2M | |
| SG&A Expense | $4M | $4M | $10M | $12M | $11M | $10M | $10M | $7M | $11M | $3M | |
| Operating Expenses | $2M | $16M | $49M | $76M | $67M | $57M | $46M | $31M | $32M | $11M | |
| Operating Income | $-2M | $-16M | $-49M | $-76M | $-67M | $-57M | $-46M | $-31M | $-32M | $-11M | |
| Other Non-op | $511.0K | $493.0K | $-2M | $-1M | $353.0K | $-3M | $-504.0K | $561.0K | $497.0K | $-1M | |
| Pretax Income | $-2M | $-16M | · | · | · | · | · | · | · | · | |
| Income Tax | $27.0K | · | · | · | · | · | · | · | · | · | |
| Net Income | $-2M | $-16M | $-52M | $-78M | $-66M | $-60M | $-46M | $-31M | $-31M | $-13M | |
| EPS (Basic) | $-0.39 | $-38.57 | $-299.95 | $-10.09 | $-0.76 | · | · | · | · | · | |
| EPS (Diluted) | $-0.39 | $-38.57 | $-299.95 | $-10.09 | $-0.76 | · | · | · | · | · | |
| Shares (Basic) | 4,908,164 | 609,696 | 172,031 | 7,684,508 | 87,885,235 | · | · | · | · | · | |
| Shares (Diluted) | 4,908,164 | 609,696 | 172,031 | 7,684,508 | 87,885,235 | · | · | · | · | · | |
| EBITDA | $-2M | $-16M | $-49M | $-76M | $-67M | $-57M | $-46M | $-31M | $-32M | $-11M |
Balance Sheet 20
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $17M | $7M | $6M | $76M | $110M | $98M | $61M | $16M | · | $27M | |
| Short-term Investments | · | · | · | · | · | · | $0 | $18M | · | · | |
| Prepaid Expense | $110.0K | $200.0K | $1M | $3M | $2M | $2M | $2M | $1M | $278.0K | $0 | |
| Current Assets | $18M | $9M | $11M | $79M | $112M | $100M | $63M | $35M | $61M | $27M | |
| PP&E (Net) | $0 | $371.0K | $3M | $8M | $11M | $8M | $8M | $7M | $1M | $0 | |
| PP&E (Gross) | · | · | $8M | $17M | $17M | $12M | $10M | $7M | $1M | · | |
| Accum. Depreciation | · | $5M | $4M | $8M | $6M | $4M | $2M | $632.0K | $2.0K | · | |
| Other Non-current Assets | $0 | $250.0K | $833.0K | $261.0K | $362.0K | $250.0K | $250.0K | $271.0K | $251.0K | $0 | |
| Total Assets | $18M | $9M | $18M | $92M | $125M | $110M | $73M | $43M | $63M | $27M | |
| Accounts Payable | $4M | $7M | $6M | $7M | $4M | $4M | $2M | $1M | $3M | $683.0K | |
| Short-term Debt | · | · | · | · | · | $0 | $1M | $0 | · | · | |
| Current Liabilities | $8M | $13M | $15M | $15M | $11M | $10M | $8M | $6M | $4M | $3M | |
| Capital Leases | $0 | $422.0K | $2M | $3M | $2M | $2M | $2M | $0 | · | · | |
| Total Liabilities | $8M | $13M | $18M | $46M | $13M | $11M | $22M | $6M | $4M | $3M | |
| Total Debt | · | · | · | · | · | $0 | $1M | · | · | · | |
| Common Stock | · | · | · | · | · | $7.0K | $4.0K | $3.0K | $3.0K | $2.0K | |
| Retained Earnings | $-399M | $-397M | $-381M | $-329M | $-252M | $-185M | $-125M | $-79M | $-48M | $-17M | |
| Stockholders' Equity | $10M | $-4M | $123.0K | $46M | $112M | $98M | $52M | $36M | $60M | $24M | |
| Liabilities + Equity | $18M | $9M | $18M | $92M | $125M | $110M | $73M | $43M | $63M | $27M | |
| Shares Outstanding | · | · | · | · | 93,582,991 | 70,920,693 | 39,403,519 | 26,610,183 | 25,236,255 | 15,165,244 |
Cash Flow 9
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $129.0K | $-450.0K | $568.0K | $2M | $3M | $3M | $3M | $5M | $2M | $0 | |
| Operating Cash Flow | $-5M | $-11M | $-49M | $-65M | $-54M | $-37M | $-34M | $-19M | $-13M | $-4M | |
| CapEx | · | $0 | $64.0K | $3M | $4M | $2M | $2M | $7M | $424.0K | · | |
| Investing Cash Flow | $1M | $0 | $6M | $-3M | $-5M | $-4M | $14M | $557.0K | $-29M | $0 | |
| Stock Issued | · | $7M | $4M | · | $0 | $37M | $32M | $0 | · | · | |
| Net Stock Activity | · | $7M | · | · | $0 | $37M | $32M | · | · | · | |
| Financing Cash Flow | $15M | $11M | $-26M | $34M | $71M | $78M | $65M | $181.0K | $50M | $32M | |
| Net Change in Cash | · | · | · | · | · | · | · | $-19M | $8M | $27M | |
| Free Cash Flow | · | $-11M | $-50M | $-68M | $-58M | $-39M | $-36M | $-26M | · | · |
Profitability 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -14.3% | -116.5% | -93.7% | -71.3% | -56.5% | -65.5% | -79.8% | -57.7% | -68.8% | -92.0% | |
| ROE | -30.9% | 251.4% | -2497.7% | -140.2% | -56.6% | -68.7% | -81.3% | -75.3% | -74.4% | -125.6% | |
| ROIC | -25.9% | · | · | · | · | · | · | · | · | · |
Liquidity & Solvency 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.2 | 0.7 | 0.7 | 5.2 | 10.3 | 10.5 | 8.1 | 6.3 | 17.0 | 8.5 | |
| Quick Ratio | 2.2 | 0.5 | 0.4 | 5.0 | 10.1 | 10.3 | 7.9 | · | · | 8.5 | |
| Debt / Equity | · | · | · | · | · | 0.0 | 0.0 | · | · | · |
Valuation (TTM) 12
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-2M | $-16M | $-52M | $-78M | $-66M | $-60M | $-46M | $-31M | $-31M | $-13M | |
| Market Cap | · | · | · | · | · | $201.33B | $120.57B | $58.68B | $226.94B | · | |
| Enterprise Value | · | · | · | · | · | $201.23B | $120.51B | · | · | · | |
| P/E | -2.5 | -0.2 | -0.2 | -29.4 | -1638.2 | · | · | · | · | · | |
| P/B | · | · | · | · | · | 2045.3 | 2334.4 | 1612.1 | 3792.9 | · | |
| P / Tangible Book | · | · | · | · | · | 2045.3 | · | · | · | · | |
| P / Cash Flow | · | · | · | · | · | -5394.7 | -3590.6 | -3049.0 | -17526.8 | · | |
| P / FCF | · | · | · | · | · | -5130.1 | -3356.2 | -2246.9 | · | · | |
| EV / EBITDA | · | · | · | · | · | -3542.4 | -2626.4 | · | · | · | |
| EV / FCF | · | · | · | · | · | -5127.6 | -3354.5 | · | · | · | |
| Earnings Yield | -39.8% | -435.8% | -444.4% | -3.4% | -0.06% | · | · | · | · | · |
Income Statement 10
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SG&A Expense | $946.0K | $880.0K | $987.0K | $957.0K | $787.0K | $1M | $-223.0K | $1M | $2M | $1M | $2M | $2M | $3M | $2M | $2M | $3M | |
| Operating Expenses | $1M | $1M | $670.0K | $624.0K | $885.0K | $253.0K | $1M | $1M | $9M | $5M | $9M | $10M | $14M | $16M | $19M | $19M | |
| Operating Income | $-1M | $-1M | $-670.0K | $-624.0K | $-885.0K | $-253.0K | $-1M | $-1M | $-9M | $-5M | $-9M | $-10M | $-14M | $-16M | $-19M | $-19M | |
| Other Non-op | $98.0K | $103.0K | $132.0K | $156.0K | $123.0K | $100.0K | $65.0K | $47.0K | $341.0K | $40.0K | $125.0K | $249.0K | $-2M | $-372.0K | $-202.0K | $-149.0K | |
| Net Income | $-1M | $-955.0K | $-538.0K | $-468.0K | $-762.0K | $-153.0K | $-952.0K | $-1M | $-8M | $-5M | $-9M | $-10M | $-16M | $-17M | $-20M | $-19M | |
| EPS (Basic) | $-0.16 | $-0.14 | $-0.08 | $-0.07 | $-0.19 | $-0.05 | $6.56 | $-1.96 | $-18.36 | $-24.81 | $-294.66 | $-1.23 | $-2.00 | $-2.06 | $-2.46 | $-2.42 | |
| EPS (Diluted) | $-0.16 | $-0.14 | $-0.08 | $-0.07 | $-0.19 | $-0.05 | $6.56 | $-1.96 | $-18.36 | $-24.81 | $-294.66 | $-1.23 | $-2.00 | $-2.06 | $-2.46 | $-2.42 | |
| Shares (Basic) | 6,732,970 | 6,729,855 | -8,215,716 | 6,241,658 | 4,021,276 | 2,860,946 | -767,003 | 720,911 | 446,587 | 209,201 | -24,220,686 | 8,171,582 | 8,127,473 | 8,093,662 | -15,134,557 | 7,850,208 | |
| Shares (Diluted) | 6,732,970 | 6,729,855 | -8,215,716 | 6,241,658 | 4,021,276 | 2,860,946 | -767,003 | 720,911 | 446,587 | 209,201 | -24,220,686 | 8,171,582 | 8,127,473 | 8,093,662 | -15,134,557 | 7,850,208 | |
| EBITDA | $-1M | $-1M | · | $-624.0K | $-885.0K | $-253.0K | · | $-1M | $-9M | $-5M | · | $-10M | $-14M | $-16M | · | $-19M |
Balance Sheet 16
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $15M | $16M | $17M | $19M | $13M | $14M | $7M | $4M | $4M | $1M | $6M | $10M | $15M | $58M | $76M | $91M | |
| Prepaid Expense | $246.0K | $107.0K | $110.0K | $160.0K | $172.0K | $211.0K | $200.0K | $84.0K | $114.0K | $1M | $1M | $4M | $3M | $3M | $3M | $3M | |
| Current Assets | · | · | $18M | $19M | $13M | $15M | $9M | $6M | $7M | $9M | $11M | $14M | $23M | $61M | $79M | $94M | |
| PP&E (Net) | · | · | $0 | $0 | $0 | $0 | $371.0K | $421.0K | $472.0K | $3M | $3M | $4M | $4M | $9M | $8M | $10M | |
| PP&E (Gross) | · | · | · | · | · | · | · | $8M | $8M | $8M | · | $8M | $8M | $18M | $17M | $18M | |
| Accum. Depreciation | · | · | · | · | · | · | · | $5M | $5M | $5M | $4M | $4M | $4M | $9M | $8M | $8M | |
| Other Non-current Assets | · | · | $0 | $0 | $0 | $0 | $250.0K | $250.0K | $250.0K | $530.0K | $833.0K | $1M | $253.0K | $257.0K | $261.0K | $320.0K | |
| Total Assets | $16M | $17M | $18M | $19M | $13M | $15M | $9M | $7M | $9M | $15M | $18M | $21M | $29M | $74M | $92M | $109M | |
| Accounts Payable | $3M | $3M | $4M | $5M | $6M | $6M | $7M | $9M | $9M | $11M | $6M | $5M | $7M | $6M | $7M | $7M | |
| Current Liabilities | $8M | $8M | $8M | $9M | $10M | $11M | $13M | $15M | $16M | $17M | $15M | $14M | $13M | $13M | $15M | $14M | |
| Capital Leases | · | · | $0 | $0 | $0 | $0 | $422.0K | $541.0K | $656.0K | $2M | $2M | $2M | $2M | $3M | $3M | $3M | |
| Total Liabilities | $8M | $8M | $8M | $10M | $10M | $11M | $13M | $16M | $17M | $20M | $18M | $17M | $15M | $44M | $46M | $45M | |
| Retained Earnings | $-401M | $-400M | $-399M | $-398M | $-398M | $-397M | $-397M | $-396M | $-394M | $-386M | $-381M | $-372M | $-362M | $-346M | $-329M | $-310M | |
| Stockholders' Equity | $8M | $9M | $10M | $10M | $3M | $4M | $-4M | $-9M | $-8M | $-5M | $123.0K | $4M | $14M | $30M | $46M | $64M | |
| Liabilities + Equity | $16M | $17M | $18M | $19M | $13M | $15M | $9M | $7M | $9M | $15M | $18M | $21M | $29M | $74M | $92M | $109M | |
| Shares Outstanding | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 106,427,767 |
Cash Flow 7
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $21.0K | $22.0K | $23.0K | $23.0K | $45.0K | $38.0K | $51.0K | $42.0K | $-619.0K | $76.0K | $188.0K | $100.0K | $45.0K | $235.0K | $473.0K | $496.0K | |
| Operating Cash Flow | $-967.0K | $-1M | $-2M | $-818.0K | $-1M | $-1M | $-2M | $-2M | $-2M | $-5M | $-7M | $-12M | $-12M | $-18M | $-15M | $-16M | |
| CapEx | · | · | · | · | · | · | · | $0 | · | · | $30.0K | $0 | $34.0K | $0 | $95.0K | $979.0K | |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 | $1M | $0 | $0 | $0 | $0 | $-30.0K | $6M | $-34.0K | $0 | $-420.0K | $-892.0K | |
| Stock Issued | · | · | · | · | · | · | · | $0 | · | · | $4M | $163.0K | · | · | · | · | |
| Financing Cash Flow | $-141.0K | $0 | $0 | $7M | $-235.0K | $8M | $5M | $1M | $5M | $49.0K | $4M | $250.0K | $-30M | $0 | $1.0K | $800.0K | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-18M | · | · |
Profitability 2
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -7.5% | -6.1% | · | -3.5% | -7.1% | -1.0% | · | -10.2% | -43.6% | -11.8% | · | -15.6% | -21.5% | -15.9% | · | -15.6% | |
| ROE | -20.5% | -15.7% | · | -84.0% | 28.0% | 22.9% | · | 60.7% | -304.6% | -41.7% | · | -29.4% | -33.9% | -26.3% | · | -20.4% |
Liquidity & Solvency 2
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | 2.1 | 1.3 | 1.3 | · | 0.4 | 0.5 | 0.5 | · | 1.0 | 1.8 | 4.8 | · | 7.0 | |
| Quick Ratio | 1.9 | 2.1 | · | 2.0 | 1.3 | 1.3 | · | 0.2 | 0.3 | 0.1 | · | 0.7 | 1.2 | 4.6 | · | 6.7 |
Valuation (TTM) 7
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-3M | $-2M | · | $-3M | $-11M | $-15M | · | $-25M | $-40M | $-48M | · | $-62M | $-71M | $-75M | · | $-75M | |
| Market Cap | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $37.44B | |
| P/E | -1.3 | -1.6 | · | -0.7 | -0.0 | -0.0 | · | -0.3 | -0.5 | -1.7 | · | -13.4 | -34.6 | -28.4 | · | -45.0 | |
| P/B | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 582.0 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 582.0 | |
| Earnings Yield | -79.8% | -61.8% | · | -149.3% | -2152.9% | -3614.4% | · | -394.6% | -196.2% | -57.9% | · | -7.4% | -2.9% | -3.5% | · | -2.2% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Net Income | $-2M | $-16M | $-52M | $-78M | $-66M |
| Diluted EPS | $-0.39 | $-38.57 | $-299.95 | $-10.09 | $-0.76 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Current Ratio | 2.2 | 0.7 | 0.7 | 5.2 | 10.3 |
| Quick Ratio | 2.2 | 0.5 | 0.4 | 5.0 | 10.1 |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Free Cash Flow | — | $-11M | $-50M | $-68M | $-58M |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 25 filers · $331K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 7 (+5 vs prior Q) | 3 (-2 vs prior Q) | 4 (0 vs prior Q) | 1 (-3 vs prior Q) | +92K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Kestra Advisory Services, LLC | $138,288 | 196,991 | 41.72% | Shares |
| CITADEL ADVISORS LLC | $41,740 | 59,459 | 12.59% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $27,586 | 39,297 | 8.32% | Shares |
| VANGUARD GROUP INC | $25,216 | 25,704 | 7.61% | Shares |
| CFO4Life Group, LLC | $23,524 | 33,510 | 7.10% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $22,548 | 32,120 | 6.80% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $18,044 | 25,704 | 5.44% | Shares |
| XTX Topco Ltd | $10,283 | 14,648 | 3.10% | Shares |
| TWO SIGMA SECURITIES, LLC | $9,647 | 13,742 | 2.91% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $9,592 | 13,664 | 2.89% | Shares |
| UBS Group AG | $2,430 | 3,461 | 0.73% | Shares |
| Tower Research Capital LLC (TRC) | $1,330 | 1,895 | 0.40% | Shares |
| BARCLAYS PLC | $787 | 1,121 | 0.24% | Shares |
| SBI Securities Co., Ltd. | $357 | 509 | 0.11% | Shares |
| MORGAN STANLEY | $83 | 118 | 0.03% | Shares |
| Virtu Financial LLC | $10 | 14,356 | 0.00% | Shares |
| Cullen/Frost Bankers, Inc. | $9 | 13 | 0.00% | Shares |
| BlackRock, Inc. | $8 | 12 | 0.00% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $4 | 6 | 0.00% | Shares |
| LANARK FINANCIAL, INC. | $2 | 3 | 0.00% | Shares |
| JPMORGAN CHASE & CO | $1 | 2 | 0.00% | Shares |
| OSAIC HOLDINGS, INC. | $1 | 2 | 0.00% | Shares |
| DANSKE BANK A/S | $1 | 2 | 0.00% | Shares |
| CWM, LLC | $1 | 2 | 0.00% | Shares |
| GROUP ONE TRADING LLC | $1 | 1 | 0.00% | Shares |
Company insiders 8 insiders · 2 officers · 7 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Manuel Litchman MD | President, CEO and Interim CFO | April 24, 2026 F | 1,615 | 0 | 0 | $0 |
| Brian Achenbach | SVP, Fin. & Corp. Controller | Dec. 14, 2021 S | 144,729 | 0 | 0 | $0 |
| David Jin | Director | Dec. 30, 2025 P | 286 | 1 | 0 | $237 |
| Adam J. Chill | Director | Dec. 30, 2025 S | 375 | 0 | 1 | $-4 |
| Neil Herskowitz | Director | Dec. 30, 2025 S | 145 | 0 | 1 | $-237 |
| Michael J Zelefsky | Director | July 5, 2023 A | 18,970 | 0 | 0 | $0 |
| Michael S Weiss | Director | July 5, 2023 A | 49,637 | 0 | 0 | $0 |
| Lindsay A. Rosenwald, M.D. | Director | July 5, 2023 A | 60,525 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 1 ETF
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0.00% | 25,704 SH | Aug. 8, 2026 | Daily |